{"id":"corticotropin-releasing-hormone","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"When CRH binds to its receptors in the anterior pituitary gland, it triggers a cascade that leads to the synthesis and secretion of ACTH. This hormone then acts on the adrenal cortex to produce and release cortisol, which plays a role in stress response and metabolism.","oneSentence":"Corticotropin-Releasing Hormone stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which in turn increases cortisol production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:29:08.633Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of major depressive disorder"}]},"trialDetails":[{"nctId":"NCT06815471","phase":"PHASE2","title":"CRF2 Agonist for the Treatment of Worsening Heart Failure","status":"RECRUITING","sponsor":"Corteria Pharmaceuticals","startDate":"2025-08-07","conditions":"Worsening Heart Failure","enrollment":300},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":"Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination","enrollment":4000},{"nctId":"NCT05703425","phase":"PHASE2","title":"The Effect of Sulfasalazine on CRH Levels in Pregnant Women","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-03-01","conditions":"Preterm Birth","enrollment":50},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":"Sleep Restriction","enrollment":80},{"nctId":"NCT05012072","phase":"NA","title":"Reducing Pregnancy Risks: The Mastery Lifestyle Intervention","status":"RECRUITING","sponsor":"Microgen LLC","startDate":"2021-08-01","conditions":"Mental Health Wellness 1, Preterm Birth","enrollment":238},{"nctId":"NCT05008146","phase":"EARLY_PHASE1","title":"Imaging CRF X NOP Interactions in CUD","status":"RECRUITING","sponsor":"Rajesh Narendran","startDate":"2020-12-31","conditions":"Cocaine Use Disorder","enrollment":80},{"nctId":"NCT06259227","phase":"NA","title":"Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury","status":"RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2024-01-11","conditions":"Incomplete Spinal Cord Injury, Exercise Training","enrollment":32},{"nctId":"NCT05071781","phase":"PHASE4","title":"Effect of CRH on Duodenal Markers and Gastric Sensorimotor Function","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-05-21","conditions":"GI Motility Disorder","enrollment":20},{"nctId":"NCT04902235","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-07-06","conditions":"Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism","enrollment":52},{"nctId":"NCT02316132","phase":"NA","title":"Confocal Laser Endomicroscopy, IBS and Stress","status":"WITHDRAWN","sponsor":"University Hospital Schleswig-Holstein","startDate":"2014-12","conditions":"Irritable Bowel Syndrome","enrollment":""},{"nctId":"NCT03302416","phase":"EARLY_PHASE1","title":"CRF - Nociceptin Receptor Interactions","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2016-06-01","conditions":"Healthy","enrollment":19},{"nctId":"NCT03613129","phase":"PHASE1, PHASE2","title":"Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"LUCINDA BATEMAN, MD","startDate":"2018-07-23","conditions":"Myalgic Encephalomyelitis, Chronic Fatigue Syndrome","enrollment":17},{"nctId":"NCT01373372","phase":"NA","title":"Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia","status":"WITHDRAWN","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2016-12","conditions":"Functional Dyspepsia","enrollment":""},{"nctId":"NCT03709381","phase":"EARLY_PHASE1","title":"Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2017-10-01","conditions":"Adrenal Insufficiency, Osteopenia, Osteoporosis, Steroid Suppression of ACTH Secretion","enrollment":10},{"nctId":"NCT03045978","phase":"","title":"The Association of Hormones and Peptides With Nutritional Consequences in Children With Feeding Difficulty.","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-09","conditions":"Feeding Difficulty","enrollment":50},{"nctId":"NCT01459237","phase":"EARLY_PHASE1","title":"Effects of Hormone Stimulation on Brain Scans for Cushing s Disease","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2011-10-11","conditions":"Pituitary Neoplasm","enrollment":30},{"nctId":"NCT01374906","phase":"PHASE3","title":"Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-11-04","conditions":"Cushing's Disease","enrollment":150},{"nctId":"NCT00756925","phase":"","title":"Gender and Neural Substrates of Stress and Craving","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2009-02","conditions":"Cocaine Dependence","enrollment":19},{"nctId":"NCT01673087","phase":"PHASE1","title":"Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-10","conditions":"Stress","enrollment":256},{"nctId":"NCT00001453","phase":"","title":"Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1995-04-10","conditions":"Cushing's Syndrome","enrollment":98},{"nctId":"NCT00385099","phase":"PHASE2","title":"Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12-08","conditions":"Irritable Colon","enrollment":10},{"nctId":"NCT00376896","phase":"PHASE1","title":"Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11","conditions":"Irritable Colon, Irritable Bowel Syndrome (IBS)","enrollment":25},{"nctId":"NCT01018992","phase":"PHASE2","title":"Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-12","conditions":"Stress Disorders, Post-Traumatic","enrollment":267},{"nctId":"NCT01187511","phase":"PHASE2","title":"CRF1 Antagonist GSK561679 in Alcoholism","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2010-01","conditions":"Alcohol Dependence","enrollment":44},{"nctId":"NCT01984177","phase":"","title":"Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-06","conditions":"Cocaine-Related Disorders, Cocaine Addiction, Substance-Related Disorders","enrollment":17},{"nctId":"NCT02736734","phase":"PHASE4","title":"The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers","status":"COMPLETED","sponsor":"Prof Dr Jan Tack","startDate":"2014-10","conditions":"Esophageal Motility Disorders","enrollment":14},{"nctId":"NCT02674256","phase":"PHASE4","title":"The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-03","conditions":"Sensitivity (Hyper); Gastrointestinal","enrollment":15},{"nctId":"NCT01227980","phase":"PHASE2","title":"Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2010-10","conditions":"Alcohol-Related Disorders, Alcohol Dependence, Alcoholism","enrollment":70},{"nctId":"NCT02349503","phase":"PHASE1","title":"Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia","status":"WITHDRAWN","sponsor":"Neurocrine Biosciences","startDate":"2015-02","conditions":"Congenital Adrenal Hyperplasia","enrollment":""},{"nctId":"NCT00088166","phase":"PHASE3","title":"XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors","status":"COMPLETED","sponsor":"Celtic Pharma Development Services","startDate":"2004-05","conditions":"Brain Edema, Brain Tumor","enrollment":200},{"nctId":"NCT00226694","phase":"NA","title":"Alcohol and Gender Effects on Stress Circuit Function","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2003-09","conditions":"Alcoholism, Stress, Alcohol Dependence","enrollment":96},{"nctId":"NCT00208897","phase":"NA","title":"Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?","status":"COMPLETED","sponsor":"Emory University","startDate":"1997-12","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT01369121","phase":"PHASE1, PHASE2","title":"Tolerability Study of Xerecept® in Pediatric Patients","status":"TERMINATED","sponsor":"Celtic Pharma Development Services","startDate":"2010-06","conditions":"Brain Edema, Brain Tumor","enrollment":15},{"nctId":"NCT01763281","phase":"PHASE4","title":"Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2012-10","conditions":"Healthy","enrollment":20},{"nctId":"NCT00744588","phase":"","title":"Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-08","conditions":"Alcohol Dependence","enrollment":75},{"nctId":"NCT00226655","phase":"PHASE3","title":"An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies","status":"COMPLETED","sponsor":"Celtic Pharma Development Services","startDate":"2005-07","conditions":"Brain Edema, Brain Tumor","enrollment":112},{"nctId":"NCT00666068","phase":"NA","title":"Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism","status":"COMPLETED","sponsor":"Max-Planck-Institute of Psychiatry","startDate":"2008-02","conditions":"Hypopituitarism","enrollment":30},{"nctId":"NCT00691522","phase":"PHASE2","title":"Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)","status":"TERMINATED","sponsor":"PharmaNet","startDate":"2008-11","conditions":"Peritumoral Brain Edema, PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS","enrollment":60},{"nctId":"NCT00001543","phase":"","title":"Dynamics of Leptin and Endocrine Function","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1996-03","conditions":"Healthy, Involutional Depression","enrollment":230},{"nctId":"NCT00001180","phase":"","title":"Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1982-03","conditions":"Adrenal Gland Hyperfunction, Adrenal Gland Hypofunction, Cushing's Syndrome","enrollment":2250},{"nctId":"NCT00226668","phase":"PHASE3","title":"XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema","status":"WITHDRAWN","sponsor":"Celtic Pharma Development Services","startDate":"2006-01","conditions":"Brain Edema, Brain Tumor","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6423,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["corticorelin"],"phase":"phase_2","status":"active","brandName":"Corticotropin-Releasing Hormone","genericName":"Corticotropin-Releasing Hormone","companyName":"Centre for Addiction and Mental Health","companyId":"centre-for-addiction-and-mental-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Corticotropin-Releasing Hormone stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland, which in turn increases cortisol production. Used for Treatment of major depressive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}